CTOR
CITIUS ONCOLOGY, INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$1.14
+11.76%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+55.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 23, 2025 | Webb Carol · director | A-Award | 300,000 | $0.00 |
| Sep 23, 2025 | HOLUBIAK MYRON Z · director, officer: Secretary | A-Award | 850,000 | $0.00 |
| Sep 23, 2025 | HOLUBIAK MYRON Z · director, officer: Secretary | A-Award | 100,000 | $0.00 |
| Sep 23, 2025 | Smith Robert Joseph · director | A-Award | 300,000 | $0.00 |
| Sep 23, 2025 | Mazur Leonard L · director, officer: Chief Executive Officer | A-Award | 1,700,000 | $0.00 |
| Sep 23, 2025 | Czuczman Myron · officer: Chief Medical Officer | A-Award | 825,000 | $0.00 |
| Sep 23, 2025 | MCGRATH DENNIS M · director | A-Award | 300,000 | $0.00 |
| Sep 23, 2025 | Bartushak Jaime · officer: Chief Financial Officer | A-Award | 825,000 | $0.00 |
| Sep 23, 2025 | Mayersohn Joel David · director | A-Award | 300,000 | $0.00 |
| Sep 23, 2025 | Dutia Suren G · director | A-Award | 300,000 | $0.00 |
| Sep 23, 2025 | Holuka Eugene Myron · director | A-Award | 300,000 | $0.00 |
| Dec 16, 2024 | Mayersohn Joel David · director | A-Award | 250,000 | $1.07 |
| Dec 16, 2024 | Holuka Eugene Myron · director | A-Award | 125,000 | $1.07 |
| Dec 16, 2024 | HOLUBIAK MYRON Z · director, officer: Secretary | A-Award | 300,000 | $1.07 |
| Dec 16, 2024 | HOLUBIAK MYRON Z · director, officer: Secretary | A-Award | 50,000 | $1.07 |
| Dec 16, 2024 | Smith Robert Joseph · director | A-Award | 125,000 | $1.07 |
| Dec 16, 2024 | Webb Carol · director | A-Award | 125,000 | $1.07 |
| Dec 16, 2024 | Dutia Suren G · director | A-Award | 125,000 | $1.07 |
| Dec 16, 2024 | MCGRATH DENNIS M · director | A-Award | 125,000 | $1.07 |
| Dec 16, 2024 | Bartushak Jaime · officer: Chief Financial Officer | A-Award | 400,000 | $1.07 |
| Dec 16, 2024 | Mazur Leonard L · director, officer: Chief Executive Officer | A-Award | 800,000 | $1.07 |
| Dec 16, 2024 | Czuczman Myron · officer: Chief Medical Officer | A-Award | 400,000 | $1.07 |
| Aug 30, 2024 | Mazur Leonard L · director, officer: Chief Executive Officer | A-Award | 3,700,000 | $2.15 |
| Aug 30, 2024 | HOLUBIAK MYRON Z · director | A-Award | 1,500,000 | $2.15 |
| Aug 30, 2024 | Czuczman Myron · officer: Chief Medical Officer | A-Award | 1,400,000 | $2.15 |
| Aug 30, 2024 | Bartushak Jaime · officer: Chief Financial Officer | A-Award | 1,400,000 | $2.15 |
| Aug 16, 2024 | Holuka Eugene Myron · director | A-Award | 150,000 | $2.15 |
| Aug 14, 2024 | Dutia Suren G · director | A-Award | 150,000 | $2.15 |
| Aug 14, 2024 | HOLUBIAK MYRON Z · director | A-Award | 500,000 | $2.15 |
| Aug 14, 2024 | Czuczman Myron · officer: Chief Medical Officer | A-Award | 466,667 | $2.15 |
Institutional positioning
13F filings over the trailing two quarters
New 10Increased 9Reduced 4Sold out 2
| Filer | Action | Shares | Filed |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | Increased | 9,188,855 | May 15, 2026 |
| ARMISTICE CAPITAL, LLC | Reduced | 8,705,589 | Aug 14, 2026 |
| BANK OF AMERICA CORP /DE/ | Unchanged | 3,835,160 | Aug 14, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 3,835,160 | May 18, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 546,325 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 534,824 | May 15, 2026 |
| UBS Group AG | Increased | 334,619 | Aug 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 264,733 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 245,407 | Aug 12, 2026 |
| VANGUARD FIDUCIARY TRUST CO | Unchanged | 121,910 | Aug 13, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 121,910 | May 8, 2026 |
| IFP ADVISORS, INC | Increased | 107,424 | Apr 13, 2026 |
| IFP Advisors, Inc | Unchanged | 107,424 | Jul 20, 2026 |
| CITADEL ADVISORS LLC | New Position | 90,586 | Sep 2, 2026 |
| BLACKROCK, INC. | Increased | 47,454 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 23, 2025